Morinda officinalis polysaccharide regulates rat bone mesenchymal stem cell osteogenic–adipogenic di...
Morinda officinalis polysaccharide regulates rat bone mesenchymal stem cell osteogenic–adipogenic differentiation in osteoporosis by upregulating miR‐21 and activating the PI3K/AKT pathway
About this item
Full title
Author / Creator
Wu, Pei‐Yu , Chen, Wen , Huang, He , Tang, Wang and Liang, Jie
Publisher
BP, Asia: Wiley Publishing Asia Pty Ltd
Journal title
Language
English
Formats
Publication information
Publisher
BP, Asia: Wiley Publishing Asia Pty Ltd
Subjects
More information
Scope and Contents
Contents
Osteoporosis (OP) is a prevailing bone metabolic disease. Morinda officinalis polysaccharide (MOP) has biological activities and medicinal potential. This study explored its mechanism in OP. Rat bone mesenchymal stem cells (rBMSCs) were pretreated with low/high concentrations of MOP and subjected to osteogenic differentiation (OD) or adipogenic dif...
Alternative Titles
Full title
Morinda officinalis polysaccharide regulates rat bone mesenchymal stem cell osteogenic–adipogenic differentiation in osteoporosis by upregulating miR‐21 and activating the PI3K/AKT pathway
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_987d73b96f7f407ba9c1e919a9fe9fb5
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_987d73b96f7f407ba9c1e919a9fe9fb5
Other Identifiers
ISSN
1607-551X
E-ISSN
2410-8650
DOI
10.1002/kjm2.12544
